RDNT / RadNet: In For A Big FY 2023, Look For De Novo Contributions

RadNet is capturing a strong demand for diagnostic imaging which benefits from several secular growth trends. The approval of new Alzheimer's drugs re more_horizontal

LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic im more_horizontal

RadNet (RDNT) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings more_horizontal

LOS ANGELES, July 21, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic ima more_horizontal

RadNet has seen a 13.5% increase in capital appreciation due to growing procedure volumes and overall profitability, with the position up 50.6% since more_horizontal

LOS ANGELES, June 05, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic ima more_horizontal

RadNet, Inc. (NASDAQ:RDNT ) Q1 2023 Earnings Conference Call May 9, 2023 10:30 AM ET Company Participants Howard Berger - Chairman, President & CEO Ma more_horizontal

RadNet (RDNT) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.15 more_horizontal